January 29, 2025 - 11:22

Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
February 7, 2026 - 19:17
Daram Secures New U.S. Patent, Strengthening Its Technology PortfolioThe technology firm Daram has announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO), a move that significantly strengthens the company`s intellectual...
February 7, 2026 - 03:18
ASMPT Extends Technology Leadership With Key TCB AOR Chip-To-Wafer MilestoneIn a significant stride for the semiconductor manufacturing industry, ASMPT has announced a key technological milestone in its Thermal Compression Bonding (TCB) process. The company has...
February 6, 2026 - 02:32
**Innovative Water Solutions Could Aid Iran's Escalating Crisis**Iran is grappling with a severe and deepening water crisis. Decades of drought, coupled with outdated irrigation practices and resource mismanagement, have pushed the nation`s reservoirs to...
February 5, 2026 - 04:57
Marquis Who’s Who Recognizes Marc Stein for Entrepreneurship and Information Technology ExcellenceMarc Stein has been selected for inclusion in Marquis Who`s Who, a distinguished honor recognizing his significant contributions to the fields of entrepreneurship and information technology. This...